Article Versions Notes

Müller A, Weyerhäuser P, Berte N, Jonin F, Lyubarskyy B, Sprang B, Kantelhardt SR, Salinas G, Opitz L, Schulz-Schaeffer W, et al. Concurrent Activation of Both Survival-Promoting and Death-Inducing Signaling by Chloroquine in Glioblastoma Stem Cells: Implications for Potential Risks and Benefits of Using Chloroquine as Radiosensitizer. Cells. 2023; 12(9):1290. https://doi.org/10.3390/cells12091290

Müller, Andreas, Patrick Weyerhäuser, Nancy Berte, Fitriasari Jonin, Bogdan Lyubarskyy, Bettina Sprang, Sven Rainer Kantelhardt, Gabriela Salinas, Lennart Opitz, Walter Schulz-Schaeffer, and et al. 2023. "Concurrent Activation of Both Survival-Promoting and Death-Inducing Signaling by Chloroquine in Glioblastoma Stem Cells: Implications for Potential Risks and Benefits of Using Chloroquine as Radiosensitizer" Cells 12, no. 9: 1290. https://doi.org/10.3390/cells12091290

Müller, A., Weyerhäuser, P., Berte, N., Jonin, F., Lyubarskyy, B., Sprang, B., Kantelhardt, S. R., Salinas, G., Opitz, L., Schulz-Schaeffer, W., Giese, A., & Kim, E. L. (2023). Concurrent Activation of Both Survival-Promoting and Death-Inducing Signaling by Chloroquine in Glioblastoma Stem Cells: Implications for Potential Risks and Benefits of Using Chloroquine as Radiosensitizer. Cells, 12(9), 1290. https://doi.org/10.3390/cells12091290